Clinical Trial Update: Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 1/2 study on converting kidney transplant patients from tacrolimus to efalizumab maintenance therapy; the trial was t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Failure
• Kidney Transplantation

Drugs mentioned

• Efalizumab (efalizumab)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Emory University | Conditions: Kidney Transplantation, Chronic Kidney Failure | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2012-12-06